Dan Budwick

8K posts

Dan Budwick banner
Dan Budwick

Dan Budwick

@DanBudwick

Founder/CEO, @1ABMedia. Brand builder & C-suite advisor for biotechs and VCs. Secretary/Director, LJ Piniella Foundation. Jersey guy/NY sports fan living in FL

Biotech hubs everywhere Katılım Şubat 2009
1.3K Takip Edilen3.2K Takipçiler
Sabitlenmiş Tweet
Dan Budwick
Dan Budwick@DanBudwick·
8 years of @1ABMedia. 17 FTEs - an amazing group of teammates I'm honored to be in the trenches with every day. A network of subcontractors and colleagues who specialize in areas we don't. The most badass client roster in biotech. And I get to do this for work. How lucky am I.
1AB@1ABMedia

In honor of our 8th anniversary today, our founder @DanBudwick reflects on the journey, how taking a leap of faith led to a life changing experience and the gratitude we share for our team and clients alike. Read the personal reflection below. linkedin.com/pulse/8-years-…

English
1
0
9
1.8K
Dan Budwick retweetledi
BiotechTV
BiotechTV@BiotechTV·
𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: @CellCentric has kicked off dosing of its first registration-supporting study for the oral p300/CBP inhibitor inobrodib in multiple myeloma today, CEO @whlwest tells us. Full video: biotechtv.com/post/cellcentr…
English
1
2
2
1.5K
Dan Budwick
Dan Budwick@DanBudwick·
@statnews @matthewherper out with a great story on how @EliLillyandCo's acquisition of Loxo Oncology reshaped the co's approach in oncology, with Jake Van Naarden leading the way - and what's next in Jake's new role in leading all of BD for the company.
English
0
0
2
155
Dan Budwick
Dan Budwick@DanBudwick·
Busy AM for @1ABMedia. $APGE $350M secondary following positive 52 wk atopic dermatitis data $MAZE positive topline data from phase 2 APOL1-mediated kidney disease trial $BEAM updated BEAM-302 data on the go-fwd 60mg dose for AATD; pivotal cohort to initiate 2H 26 And...
English
1
1
3
1.3K
Dan Budwick retweetledi
Matthew Herper
Matthew Herper@matthewherper·
A white envelope. An $8 billion deal. A red-eye flight to buy a drug out of bankruptcy. How Eli Lilly’s cancer chief, Jacob Van Naarden, rewrote the company’s plans in oncology — and quietly became its top dealmaker. Also: why biotechs keep turning down good offers… and why targeted drugs for rare cancers are so brutally hard to develop. statnews.com/2026/03/25/eli…  $LLY
English
3
23
119
24.6K
Dan Budwick retweetledi
BiotechTV
BiotechTV@BiotechTV·
𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: Apogee Therapeutics' CEO Michael Henderson discusses today's 52 week maintenance data for the company's extended-dose IL-13 inhibitor in atopic dermatitis. $APGE Full video: biotechtv.com/post/apogee-th…
English
1
3
17
5.2K
Dan Budwick
Dan Budwick@DanBudwick·
Awesome job, @AshleaOnAir - and you too, Ray! 😛 $GPCR
1AB@1ABMedia

We're at the @NYSE today with the team at @StructureTx for their live segment on @CNBC. Structure is on a mission to develop more accessible oral small molecule therapeutics for the treatment of #obesity. We're proud to play a small role in bringing their mission to life. $GPCR

English
0
0
2
379
Dan Budwick
Dan Budwick@DanBudwick·
Apogee Tx $APGE - Positive 52 wk maintenance data from Part A of Phase 2 APEX clinical trial of zumilokibart (APG777). Durable response with both 3- and 6-month dosing, deepening of response across lesional and itch, significantly less frequent dosing than SOC. Call at 8am ET.
Dan Budwick tweet media
English
1
2
6
1.1K
Dan Budwick
Dan Budwick@DanBudwick·
Quick trip to NYC yesterday to catch up with reporters and attend the STAT #STATBreakthrough Summit East. FDA and China not surprisingly continue to be in focus for pharma/biotech and the reporters tracking the industry. Interesting year ahead!
Dan Budwick tweet media
English
0
0
1
202
Dan Budwick retweetledi
Corsera Health
Corsera Health@corserahealth·
Our mission is to extend healthspan through early prediction and effective prevention of #CVD. Guided by the core values below, we work together toward a shared goal of redefining the future of #hearthealth - because what we’re working toward is bigger than us.
English
0
3
2
851
Dan Budwick retweetledi
Drew Armstrong
Drew Armstrong@ArmstrongDrew·
🔥Some great news here at @endpts -- We've hired Karen Weintraub and Kevin Miller as our newest editors! 🧪Karen joins us after a long career in health and science journalism at USA Today. 📈Kevin joins from Bloomberg, where we worked together for years on business coverage
Drew Armstrong tweet mediaDrew Armstrong tweet media
English
6
3
40
4.9K
Max Bayer
Max Bayer@maxonwifi·
Career news: I've been promoted to senior reporter. HOORAY! @endpts rocks and I love this newsroom. I'll still be covering large drugmakers and their dealings in Washington, from FDA to Congress to the WH. Tips/memes/rants to mbayer@endpointsnews.com or maxbayer.10 on Signal.
English
21
2
135
4.5K
Dan Budwick
Dan Budwick@DanBudwick·
$GPCR 8:30am ET investor call on positive topline Phase 2 ACCESS II study for its investigational once-daily, oral small molecule GLP-1 drug candidate Aleniglipron
Structure Therapeutics@StructureTx

We're pleased to announce positive topline data from the ACCESS clinical program of aleniglipron for the treatment of people living with #obesity and/or overweight with at least one weight related co-morbidity. This includes 44-week data from the Phase 2 ACCESS II study and interim data from the ongoing body composition study and the ACCESS open label extension study. Read more: ir.structuretx.com/news-releases/…

English
0
0
2
882

Keşfet

@CellCentric @whlwest @statnews @matthewherper @EliLillyandCo @1ABMedia @AshleaOnAir @endpts